؉ CD25 ؉ regulatory T cells (T Reg ) play a critical role in the control of autoimmunity. However, little is known about how T Reg suppress self-reactive T cells in vivo, thus limiting the development of T Reg -based therapy for treating autoimmune diseases. This is in large part due to the dependency on a state of lymphopenia to demonstrate T Reg -mediated suppression in vivo and the unknown Ag specificity of T Reg in most experimental models. Using a nonlymphopenic model of autoimmune pneumonitis and T Reg with known Ag specificity, in this study we demonstrated that these T Reg can actively suppress activation of self-reactive T cells and protect mice from fatal autoimmune pneumonitis. The protection required T Reg with the same Ag specificity as the self-reactive T cells and depended on IL-10 and TGF-␤. These results suggest that suppression of autoimmunity by T Reg in vivo consists of multiple layers of regulation and advocate for a strategy involving Ag-specific T Reg for treating organ-specific autoimmunity, because they do not cause generalized immune suppression. The Journal of Immunology, 2005, 175: 4283-4291. R epresenting 5-10 and 2-4% of the peripheral CD4 ϩ T cells in healthy adult mice and humans, respectively, CD4 ϩ CD25 ϩ regulatory T cells (T Reg ) 3 play important roles in the maintenance of self-tolerance and the control of autoimmunity (1-3). These T Reg have been characterized by the expression of IL-2R ␣-chain (CD25), CTLA-4 (4, 5), glucocorticoidinduced TNFR (GITR) (6, 7), and more recently identified T Regspecific transcription factor, forkhead/winged helix transcription factor (Foxp3) (8 -10). It has been shown that the majority of CD4 ϩ CD25 ϩ T Reg are of thymic origin (11-13), although in some cases T Reg may be generated in the periphery as well (13-16). Despite these progresses, how T Reg suppress self-reactive T cells in vivo remains uncertain, thus impeding the development of therapeutic strategies involving T Reg for treating autoimmune diseases.
R
epresenting 5-10 and 2-4% of the peripheral CD4 ϩ T cells in healthy adult mice and humans, respectively, CD4 ϩ CD25 ϩ regulatory T cells (T Reg ) 3 play important roles in the maintenance of self-tolerance and the control of autoimmunity (1-3). These T Reg have been characterized by the expression of IL-2R ␣-chain (CD25), CTLA-4 (4, 5), glucocorticoidinduced TNFR (GITR) (6, 7), and more recently identified T Regspecific transcription factor, forkhead/winged helix transcription factor (Foxp3) (8 -10). It has been shown that the majority of CD4 ϩ CD25 ϩ T Reg are of thymic origin (11-13), although in some cases T Reg may be generated in the periphery as well (13-16). Despite these progresses, how T Reg suppress self-reactive T cells in vivo remains uncertain, thus impeding the development of therapeutic strategies involving T Reg for treating autoimmune diseases.
It has been shown that in vitro, CD4 ϩ CD25 ϩ T Reg -mediated suppression on T cell activation requires cell-cell contact, but is independent of cytokines such as IL-10 or TGF-␤ (17, 18). In contrast to in vitro models, IL-10 and TGF-␤ have been implicated in T Reg -mediated suppression in vivo; however, their precise roles remain controversial, because they are model and context dependent (19 -23) . This uncertainty could be due in part to the dependency on a state of lymphopenia to demonstrate T Reg -mediated suppression in most in vivo models. The presence of homeostatic signals in the setting of lymphopenia could complicate the interpretation of T Reg -mediated immune regulation in vivo. Consistent with this idea, recent studies indicated that dysregulated expansion of potentially pathogenic T cells in a lymphopenic environment can be prevented even by naive T cells regardless of their specificity as a side effect of their response to homeostatic stimulation (24). Therefore, a nonlymphopenic model is required to address the mechanisms of T Reg -mediated suppression in vivo.
Although CD4 ϩ CD25 ϩ T Reg -mediated suppression in vitro is non-Ag specific (18, 25), the role of Ag specificity in T Reg -mediated suppression in vivo remains unknown. In fact, some early experiments suggested a role of Ag specificity in T Reg cell-mediated regulation in vivo. It has been shown in the day 3 thymectomy models that splenocytes from female donors or orchidectomized male donors were less effective in preventing autoimmune orchitis than those from normal male donors (26). Furthermore, CD4
ϩ T cells from athyroid rats effectively suppressed autoimmune diabetes, but not autoimmune thyroiditis (27) . Thus, to determine whether CD4 ϩ CD25 ϩ T Reg regulate autoimmunity toward pathogenic T cells with the same Ag specificity or different epitopes in a bystander manner, it is necessary to develop a model using CD4 ϩ CD25 ϩ T Reg with known Ag specificity for regulation of autoimmunity.
To address these questions directly, we used a nonlymphopenic model of autoimmune pneumonitis in influenza hemagglutinin (HA)-transgenic mice (C3-HA) that express HA as a self-Ag in a variety of organs, including lung (28, 29). Previous studies have shown that adoptive transfer of naive HA-specific T cells from TCR-HA transgenic mice (clone 6.5) into C3-HA high mice that express high levels of the HA transgene led to activation of HAspecific T cells and development of fatal autoimmune pneumonitis within 4 -7 days after transfer (30). We have also observed that the naive HA-specific T cells failed to elicit mortality when transferred into C3-HA high and TCR-HA double-transgenic mice. In this study we showed that C3-HA high and TCR-HA double-transgenic mice had abundant HA-specific CD4 ϩ CD25 ϩ T cells with regulatory function. Adoptive transfer of purified HA-specific CD4 ϩ CD25 ϩ T Reg into C3-HA high mice suppressed activation of naive HAspecific T cells and protected mice against fatal autoimmune pneumonitis. The suppression in vivo was dependent on IL-10 and TGF-␤ and required T Reg with the same Ag specificity as the self-reactive T cells. Using this approach, we demonstrate that CD4 ϩ CD25 ϩ T Reg can suppress self-Ag-driven activation of autoreactive T cells in vivo and prevent autoimmunity in a nonlymphopenic environment through both IL-10 and TGF-␤ in an Ag-specific manner.
Materials and Methods

Mice
B10.D2 and BALB/c mice (H-2 d ) were purchased from The Jackson Laboratory. The C3-HA transgenic mice were provided by Dr. D. Pardoll (Johns Hopkins University, Baltimore, MD) and have been described previously (28, 29, 31). The 6.5 TCR-HA transgenic mice on the BALB/c background that express a TCR recognizing an I-E d -restricted HA epitope ( 110 SFERFEIFPKE) (12) were provided by Dr. H. von Boehmer (Harvard University, Boston, MA) (32). Some of these mice were backcrossed for more than nine generations onto the Thy1.1 ϩ or Thy1.2 ϩ B10.D2 genetic background. The DO11.10 TCR-OVA transgenic mice in BALB/c background that express a TCR recognizing an I-A d -restricted OVA epitope ( 323 ISQAVHAAHAEINEAGR) (33) were purchased from The Jackson Laboratory (33). RAG-2 Ϫ/Ϫ mice were purchased from Taconic Farms. TCR-OVA, TCR-HA, and TCR-HA ϫ C3-HA high on a RAG-2 Ϫ/Ϫ background were bred in our animal facility. All mice used in these studies were between 8 and 12 wk of age. Experimental procedures were performed in accordance with protocols approved by the Animal care and use committee of Duke University Medical Center.
Adoptive transfer
Naive clonotypic HA-and OVA-specific T cells were prepared from TCR-HA and TCR-OVA transgenic mice on a RAG-2 Ϫ/Ϫ background as described previously (34) and transferred into recipients in 0.2 ml of HBSS. For transfer of clonotypic CD4 ϩ CD25 ϩ T cells, single-cell suspensions were prepared from TCR-HA ϫ C3-HA double-transgenic mice. CD4 ϩ T cells were enriched through depleting non-CD4 cells by a mixture of biotinylated mAbs, followed by anti-biotin MicroBeads (Miltenyi Biotec). Enriched CD4 ϩ T cells were then subjected to cell sorting gated on 6.5 ϩ CD4 ϩ CD25 ϩ vs 6.5 ϩ CD4 ϩ CD25 Ϫ cells with a high speed cell sorter FACSVantage (BD Biosciences). The purity of FACS sorted populations of cells was Ͼ98%.
In vivo Ab blocking
For in vivo cytokine blocking experiments, mice were injected with 0.5 mg of anti-TGF-␤ (1D11) Ab (R&D Systems), anti-IL-10R (1B1.3a) Ab (BD Pharmingen), or the control rat IgG (Jackson ImmunoResearch Laboratories) i.v. 6 h before adoptive transfer of naive transgenic T cells. Mice were monitored for survival or were harvested for analyses.
Flow cytometry
The following mAbs were purchased from BD Pharmingen: anti-CD4 (RM4-5), anti-Thy1.1 (OX-7), anti-CD44 (1M7), anti-IL-10 (JES5), anti-CD25 (7D4), anti-CTLA4 (UC10), anti-TGF-␤ (A75-3.1), anti-TCR-OVA (KJ1-26), and anti-IFN-␥ (XMG1.2). Anti-GITR mAb (108619) was purchased from R&D Systems. Anti-TCR-HA Abs (6.5) were purified and conjugated in our laboratory. Cells were stained with the desired mAbs and subjected to FACS analysis using FACSCalibur (BD Biosciences). To assess the production of IFN-␥ or IL-10 intracellularly, cells were incubated in the presence of 10 g/ml I-E d -HA epitope peptide and 5 g/ml brefeldin A containing Golgi-Plug (BD Pharmingen) for 6 h at 37°C. After washing, cells were stained with CD4 and Thy1.1 and permeabilized to detect intracellular IFN-␥ or IL-10 using the Cytofix/Cytoperm kit (BD Pharmingen) according to the manufacturer's instructions.
Real-time RT-PCR
Total RNA was extracted from 5 ϫ 10 5 sorted cells using TRIzol (Invitrogen Life Technologies). Oligo(dT) 15 -primed cDNA was generated with ImProm-II reverse transcriptase (Promega). The expression of Foxp3 and hypoxanthine phosphoribosyltransferase (HPRT) was quantified by realtime PCR using the TaqMan Universal PCR MasterMix (Applied Biosystems) as well as the following primers and internal fluorescent probes: Foxp3, 5Ј-GGC CCT TCT CCA GGA CAG A-3Ј, 5Ј-GCT GAT CAT GGC TGG GTT GT-3Ј, and 5Ј-FAM ACT TCA TGC ATC AGC TCT CCA CTG TGG AT-TAMRA-3Ј; or HPRT, 5Ј-TGA AGA GCT ACT GTA ATG ATC AGT CAA C-3Ј, 5Ј-AGC AAG CTT GCA ACC TTA ACC A-3Ј, and 5Ј-FAM-TGC TTT CCC TGG TTA AGC AGT ACA GCC C-TAMRA-3Ј. The normalized value for Foxp3 mRNA expression in each sample was calculated as the relative quantity of Foxp3 derided by the relative quantity of HPRT (ϫ100).
Proliferation assay
Naive 6.5 ϩ CD4 ϩ cells (2.5 ϫ 10 4 ) from TCR-HA mice were cultured in the presence of irradiated (3000 rad) B10.D2 splenocytes (2.5 ϫ 10 5 ) and 10 g/ml of the I-E d -HA peptide. For in vitro suppression experiments, sorted 6.5 ϩ CD4 ϩ CD25 ϩ (2.5 ϫ 10 4 ) or 6.5 ϩ CD4 ϩ CD25 Ϫ (2.5 ϫ 10 4 ) cells were added to the wells. Incorporation of [ 3 H]thymidine (1 Ci/well) during the last 18 h of a 66-h culture was measured by scintillation counting. In some experiments mice were harvested 4 days after transfer of T cells and examined for pulmonary pathology by H&E staining and for T cell infiltration by immunohistochemistry using Thy1.1 mAb. C, CFSElabeled naive HA-specific T cells (Thy1.1 ϩ ) were used for transfer. Four days later, lymphocytes from hilar LNs were analyzed for in vivo divisions (by CFSE dilution) and function (by intracellular IFN-␥ staining). For CFSE dilution, events were gated on CD4 ϩ Thy1.1 ϩ T cells; for intracellular IFN-␥ staining, events were gated on CD4 ϩ T cells. D, C3-HA high mice (n ϭ 10 for each group) were adoptively transferred with 5 ϫ 10 6 , 2.5 ϫ 10 6 , 1.2 ϫ 10 6 , 6 ϫ 10 5 , 3 ϫ 10 5 , or 1 ϫ 10 5 of naive HA-specific T cells and monitored for survival. Representative data of three independent experiments are shown.
MECHANISMS FOR CD4
ϩ CD25 ϩ T Reg -MEDIATED SUPPRESSION IN VIVO
Dendritic cell (DC) preparation
Bone marrow-derived DCs were generated as previously described (34). Briefly, bone marrow cells were cultured in the presence of murine GM-CSF (1000 U/ml) and IL-4 (500 U/ml) for 5 days. On day 5, cells were harvested and transferred onto a new plate in the above-described DC medium with addition of TNF (500 U/ml). On day 7, DCs were harvested and loaded with HA and OVA peptides for immunization.
Histopathology and immunohistochemistry
Paraffin sections (5 m) were stained with H&E according to standard procedures. Random sections were examined for histopathology in a blinded fashion. Detection of donor-derived Thy1.1 ϩ cells was performed by immunohistochemistry as previously described (31).
Results
A model of fatal autoimmune pneumonitis
To determine whether CD4 ϩ CD25 ϩ T Reg can inhibit self-Ag driven activation of autoreactive T cells in vivo in the absence of homeostatic signals, we first further characterized a previously described mouse model of autoimmune pneumonitis using C3-HA transgenic mice (30). Adoptive transfer of 1.2 ϫ 10 6 naive HAspecific T cells (Thy1.1 ϩ ) into C3-HA high mice that express high levels of HA in a variety of organs, including lung, led to 100% mortality in recipients within 5-6 days after transfer (Fig. 1A) . Pulmonary pathology revealed that these animals developed severe pneumonitis characterized by perivascular and alveolar infiltration (Fig.  1B) . Immunohistochemistry with anti-Thy1.1 Ab indicated that the pulmonary infiltrate was mainly composed of donor-derived, self-reactive T cells (Fig. 1B) . Four days after transfer of CFSE-labeled naive HA-specific T cells, vigorous proliferation was detected in spleen and hilar lymph nodes (LNs) including at least six divisions in C3-HA high mice (Fig. 1C) . Extensive proliferation resulted in activation of self-reactive T cells and development of effector function, indicated by their ability to produce IFN-␥ (Fig. 1C) . Neither mortality nor T cell activation was observed when naive HA-specific T cells were transferred into nontransgenic B10.D2 mice or C3-HA low mice that express low levels of HA in the lung (ϳ500-to 1000-fold lower than that of C3-HA high mice) (29), suggesting that induction of fatal pneumonitis was Ag specific and was dependent on the levels of self Ag expression in the target organ (Fig. 1, A and B) . The mortality of C3-HA high mice was also related to the number of clonotypic T cells transferred in a dose-dependent manner (Fig. 1D) .
Protection against pulmonary lethality in C3-HA high ϫ TCR-HA double-transgenic mice
We next looked at whether the observed mortality can be induced by intercrossing TCR-HA transgenic mice with C3-HA high mice. A, C3-HA high or C3-HA high ϫ TCR-HA mice (n ϭ 10 for each group) were adoptively transferred with 1.2 ϫ 10 6 or 5 ϫ 10 6 of naive HA-specific T cells and monitored for survival. B, CFSE-labeled naive HA-specific T cells (Thy1.1 ϩ ) were transferred into C3-HA high or C3-HA high ϫ TCR-HA mice, and cells were analyzed for in vivo divisions and function of TCR-HA T cells. For CFSE dilution, events were gated on CD4 ϩ Thy1.1 ϩ T cells; for intracellular IFN-␥ staining, events were gated on CD4 ϩ T cells. Representative data of two independent experiments are shown.
FIGURE 3. Generation of clonotypic CD4
ϩ CD25 ϩ T cells in C3-HA high ϫ TCR-HA double-transgenic mice. A, Thymus, spleen, and peripheral LNs were harvested from C3-HA high or C3-HA high ϫ TCR-HA mice at 8 wk of age. Single-cell suspensions were stained with anti-CD4, anti-TCR-HA (6.5), and anti-CD25. For thymus, events were gated on 6.5 ϩ CD4 ϩ CD8 Ϫ cells; for spleen and LNs, events were gated on 6.5 ϩ CD4 ϩ cells. B, Cells were harvested from 8-wk-old C3-HA high RAG-2 Ϫ/Ϫ or C3-HA high ϫ TCR-HA RAG-2 Ϫ/Ϫ mice and analyzed as described.
Although there was a reduction in the number of TCR-HA ϫ C3-HA high double-transgenic litters compared with that of TCR-HA or C3-HA high single-transgenic ones, the double-transgenic mice survive well after birth. Furthermore, these double-transgenic mice became refractory to naive HA-specific T cell-induced pulmonary lethality ( Fig. 2A) . No mortality was observed even with a dose of 5 ϫ 10 6 HA-specific T cells ( Fig. 2A) . When CFSE-labeled naive HA-specific T cells were transferred into these double-transgenic mice, very little activation of self-reactive T cells, characterized by poor proliferation and no effector function, was detected in hilar LNs (Fig. 2B) . These results suggested that protection against lethal pneumonitis in C3-HA high ϫ TCR-HA double-transgenic mice was probably due to lack of self-reactive T cell activation.
We next observed that in double-transgenic mice, there was a large population of clonotypic HA-specific CD4 ϩ T cells (6.5 ϩ CD4 ϩ ) that expressed CD25 (Fig. 3) . These 6.5 ϩ CD4 ϩ CD25 ϩ T cells (referred to as 6.5 ϩ CD25 ϩ ) were abundant in secondary lymphoid tissues, such as spleen and peripheral LNs (Fig. 3A) . They expressed high levels of CTLA-4, GITR, IL-10, and TGF-␤ compared with 6.5 ϩ CD25 Ϫ T cells from the same mouse (Fig. 4A) . Thus, the phenotype of 6.5 ϩ CD25 ϩ T cells suggested that they were T Reg . Indeed, when the expression of the T Reg -specific marker, Foxp3 (8 -10), was analyzed by real-time PCR, high levels of Foxp3 mRNA were detected in sorted 6.5 ϩ CD25 ϩ T cells (Fig.  4B) . The level of Foxp3 expression in 6.5 ϩ CD25 ϩ T cells was comparable to that in naturally occurring polyclonal CD4 ϩ CD25 ϩ T Reg cells from B10.D2 mice (Fig. 4B) . To study whether 6.5 ϩ CD25 ϩ T cells were derived from the thymus, we analyzed the presence of 6.5 ϩ CD25 ϩ T cells in the CD4 ϩ CD8 Ϫ fraction of thymocytes. Similar to the peripheral lymphoid organs, 6.5 ϩ CD25 ϩ T cells were also abundant in the thymus of C3-HA high ϫ TCR-HA double-transgenic mice (Fig. 3A) . These results suggest that 6.5 ϩ CD25 ϩ T cells may also have arisen as a result of the intrathymic expression of HA (28, 29). To investigate whether the development of 6.5 ϩ CD25 ϩ T cells required endogenous TCR chains, we bred C3-HA high ϫ TCR-HA mice onto a RAG-2-deficient background (Fig. 3B) . Consistent with previous reports, the small amount of 6.5 ϩ CD25 ϩ T cells that developed in TCR-HA single-transgenic mice required endogenous TCR chains, because they did not arise in TCR-HA RAG-2 Ϫ/Ϫ mice (Fig. 3) (12, 13, 18) . However, the development of 6.5 ϩ CD25 ϩ T cells was intact in C3-HA high ϫ TCR-HA mice bred onto a RAG-2 Ϫ/Ϫ background (Fig. 3B ), arguing against a requirement for the rearrangement of endogenous TCRs for the development of the 6.5 ϩ CD25 ϩ T cells in C3-HA high ϫ TCR-HA mice.
Clonotypic CD4 ϩ CD25 ϩ T cells suppress naive TCR-HA T cell response in vitro
To confirm that 6.5 ϩ
CD25
ϩ T Reg possess regulatory function, we analyzed their suppressive activity in vitro. Purified 6.5 ϩ CD25 ϩ cells potently suppressed the proliferation of naive HA-specific T (Fig. 4C) . Separation of 6.5 ϩ CD25 ϩ T Reg from naive HA-specific T cells by a Transwell abrogated suppression of these cells (Fig. 4C) . In addition, the suppressive activity of 6.5 ϩ CD25 ϩ T Reg did not require IL-10 or TGF-␤, because the addition of anti-IL-10 or anti-TGF-␤ Ab did not ablate suppression (Fig. 4C) . Thus, similar to the property of naturally occurring polyclonal CD4 ϩ CD25 ϩ T Reg (17, 18), these results indicate that the suppressive activity of 6.5 ϩ CD25 ϩ T Reg is cell contact dependent and cytokine independent in vitro.
Clonotypic CD4 ϩ CD25 ϩ T Reg protect against lethal autoimmune pneumonitis in vivo
We next examined the capacity of 6.5 ϩ CD25 ϩ T Reg cells to inhibit fatal autoimmune pneumonitis in C3-HA high mice. Purified 6.5 ϩ CD25 ϩ T Reg cells were then transferred into C3-HA high recipients, which were subsequently challenged i.v. with naive HAspecific T cells (Thy1.1 ϩ ) to induce lethal autoimmune pneumonitis. Adoptive transfer of 6.5 ϩ CD25 ϩ T Reg completely protected C3-HA high mice from pulmonary lethality (Fig. 5A ) compared with 100% mortality in the C3-HA high mice that received only naive HA-specific T cells (Fig. 1A) . However, transfer of 6.5 ϩ CD25 Ϫ T cells generated from the same group of mice failed to prevent mortality (Fig. 5A) . The protection from fatal pneumonitis by 6.5 ϩ CD25 ϩ T Reg cells was accompanied by a notable reduction in perivascular and alveolar infiltration compared with no reduction of infiltration by transfer of 6.5 ϩ CD25 Ϫ T cells (Fig. 5B) . Immunohistochemistry with anti-Thy1.1 Ab indicated that transfer of 6.5 ϩ CD25 ϩ T Reg cells inhibited the infiltration of donor-derived self-reactive T cells (Thy1.1 ϩ ). When CFSE-labeled naive HAspecific T cells were used for the challenge experiment, transfer of 6.5 ϩ CD25 ϩ T Reg cells, but not 6.5 ϩ CD25 Ϫ T cells, suppressed proliferation as well as the development of effector function by HA-specific T cells (Fig. 5C ). Taken together, these results showed that the clonotypic CD4 ϩ CD25 ϩ T Reg possessed the capacity to protect mice from lethal autoimmune pneumonitis through suppressing the activation of self-reactive T cells in nonlymphopenic mice.
Clonotypic T Reg -mediated protection in vivo is Ag specific
To test whether polyclonal T Reg can also suppress naive HA-specific T cell-induced pneumonitis, we purified 6.5 ϩ CD25 ϩ T cells from B10.D2 mice. These mice were then challenged with 1.2 ϫ 10 6 of naive HA-specific T cells (Thy1.1 ϩ ) and monitored for survival and pulmonary pathology. A, Kaplan-Meier survival curve. Data represent the percent survival over time after transfer of naive HA-specific T cells. B, Pulmonary pathology. Four days after transfer of naive HA-specific T cells, pulmonary pathology was examined by H&E staining or immunohistochemistry for infiltration by donor-derived T cells using Thy1.1 mAb. C, Four days after transfer, cells from hilar LNs were analyzed for in vivo divisions and function of HA-specific T cells. For CFSE dilution, events were gated on CD4
ϩ Thy1.1 ϩ T cells; for intracellular IFN-␥ staining, events were gated on CD4 ϩ T cells. D, Different doses (1.2 ϫ 10 6 , 2.5 ϫ 10 6 , or 5 ϫ 10 6 ) of polyclonal CD4 ϩ CD25 ϩ T cells from B10.D2 mice were transferred into C3-HA high mice, which were then challenged with 1.2 ϫ 10 6 of naive HA-specific T cells (Thy1.1 ϩ ) and monitored for survival. Representative data of three independent experiments are shown.
polyclonal CD4
ϩ CD25 ϩ T Reg cells did not protect mice from fatal pneumonitis (Fig. 5A) . Neither reduction of pulmonary infiltrate (Fig. 5B) nor suppression of naive HA-specific T cell activation (Fig. 5C ) was noted in mice transferred with 6.5 Ϫ CD25 ϩ T Reg or polyclonal CD4 ϩ CD25 ϩ T Reg . These results suggested that suppression of self-reactive T cell activation and prevention of autoimmunity by T Reg in vivo required T Reg cells with the same Ag specificity.
To test whether differential expansion of clonotypic 6.5 ϩ CD25
ϩ T Reg vs polyclonal CD4 ϩ CD25 ϩ T Reg in C3-HA high mice contributes to the observed Ag specificity in T Reg -mediated suppression in vivo, we first transferred purified 6.5 ϩ CD25 ϩ T Reg or polyclonal CD4 ϩ CD25 ϩ T Reg cells and followed their expansion over time in vivo (Table I ). Transfer of 6.5 ϩ CD25 ϩ T Reg and CD4 ϩ CD25 ϩ T Reg cells led to 3-to 4-fold and 2-to 2.5-fold expansion, respectively, by day 15 in both spleen and hilar LNs in C3-HA high mice, consistent with previous observations that T Reg are not anergic in vivo and can undergo limited expansion in response to Ag stimulation (35-38). Because we observed that expansion of 6.5 ϩ CD25 ϩ T Reg was slightly more efficient than that of polyclonal CD4 ϩ CD25 ϩ T Reg , we examined whether transfer of escalated doses of polyclonal CD4 ϩ CD25 ϩ T Reg protected C3-HA high mice from HA-specific, T cell-induced pneumonitis. As shown in Fig. 5D , no protection was observed even with a dose of 5 ϫ 10 6 of CD4 ϩ CD25 ϩ T Reg (8-fold higher than 6.5 ϩ CD25 ϩ T Reg ), suggesting that the slight difference in expansion did not contribute to the observed Ag specificity in T Reg -mediated suppression in vivo.
To further confirm the requirement for Ag specificity in T Regmediated suppression in vivo, we tested whether 6.5 ϩ CD25 ϩ T Reg could suppress the activation of naive T cells with a different specificity. BALB/c mice were transferred with a mix of naive HAspecific (2 ϫ 10 5 ; Thy1.1 ϩ ) and naive OVA-specific (2 ϫ 10 5 ) T cells i.v. and challenged with mature DCs loaded with both HA and OVA peptides in the presence or the absence of 6.5 ϩ CD25 ϩ , HA-specific T Reg . Naive HA-specific T cells and OVA-specific T cells were detected by anti-Thy1.1 Ab and the clonotypic Ab to OVA-TCR, KJ1-26. In the absence of 6.5 ϩ CD25 ϩ T Reg , immunization with DCs loaded with both HA and OVA peptide rapidly expanded both HA-specific and OVA-specific T cells compared with the controls using DCs not loaded with peptide (Fig. 6) . However, cotransfer of 6.5 ϩ CD25 ϩ T Reg significantly ( p Ͻ 0.001) abrogated the expansion of HA-specific T cells (Fig. 6 ). In contrast, the expansion of OVA-specific T cells was not affected by the presence of 6.5 ϩ CD25 ϩ T Reg cells (Fig. 6) . These results indicate that T Reg -mediated suppression in vivo in nonlymphopenic hosts is Ag specific.
Clonotypic T Reg -mediated protection in vivo is mediated by IL-10 and TGF-␤
Although IL-10 and TGF-␤ did not seem to play a role in 6.5 ϩ CD25 ϩ T Reg -mediated suppression in vitro (Fig. 4C) , 6.5 ϩ CD25 ϩ T Reg cells from C3-HA high ϫ TCR-HA double-transgenic mice secreted high levels of IL-10 and TGF-␤ (Fig. 4A) . Thus, it was of interest to determine whether IL-10 and TGF-␤ played a role in the protection of mice from lethal autoimmune pneumonitis. 6.5 ϩ CD25 ϩ T Reg cells were transferred into C3-HA high recipients, and mice were challenged with naive HA-specific T cells. Before transfer, mice were treated with 0.5 mg of anti-IL-10, anti-TGF-␤, or control Ab. Surprisingly, mice treated with anti-IL-10 or anti-TGF-␤ Ab succumbed with 100% mortality within 8 days after transfer of naive HA-specific T cells (Fig. 7A) . In vivo blocking of IL-10 or TGF-␤ was associated with increased proliferation and gain of effector function by the self-reactive T cells in the presence of 6.5 ϩ
CD25
ϩ T Reg cells (Fig. 7B) . These results suggest that in addition to Ag-specific regulation by T Reg , both IL-10 and TGF-␤ were required for T Reg -mediated suppression in vivo and protection from the lethal autoimmune pneumonitis.
Discussion
In this study we have characterized HA-specific CD4 ϩ CD25 ϩ T Reg . In vitro, these Ag-specific T Reg were phenotypically and functionally indistinguishable from the naturally occurring CD4 ϩ CD25 ϩ T Reg . Using a murine model of autoimmune pneumonitis, we showed that these HA-specific T Reg can protect mice from fatal autoimmune pneumonitis in vivo. This was accomplished by inhibiting self-HA-driven activation of naive HA-specific T cells. In this nonlymphopenic model, the T Reg -mediated suppression in vivo was Ag specific and critically dependent on both IL-10 and TGF-␤.
Despite accumulating evidence that CD4 ϩ CD25 ϩ T Reg play a crucial role in the control of autoimmunity (1, 2), very little is known about how they function in vivo. This is largely due to the limitations in current models for T Reg -mediated suppression in vivo. One of them is that most models heavily rely on a state of lymphopenia to demonstrate T Reg -mediated suppression (39 -43) . The presence of homeostatic signals in the lymphopenic environment has made it difficult to discern whether T Reg -mediated suppression on naive or effector T cells in vivo is due to competition for space or cytokines (24) or to active suppression of self-Agdriven activation of autoreactive T cells. Using a nonlymphopenic model of autoimmune pneumonitis, in this study we provide direct evidence that CD4 ϩ CD25 ϩ T Reg can inhibit self-Ag-driven activation of autoreactive T cells in vivo in the absence of homeostatic signals. Furthermore, our findings that only 6.5 ϩ CD25 ϩ T Reg , but not 6.5 ϩ CD25 Ϫ T, cells inhibit activation of naive HA-specific T cells suggest that this is a process of active suppression, rather than intraclonal T cell competition for available space or cytokines.
Another limitation is that in most in vivo models, the Ag specificity of the CD4 ϩ CD25 ϩ T Reg cells is unknown. Thus, whether CD4 ϩ CD25 ϩ T Reg cells suppress the activation of self-reactive T cells with the same Ag specificity or different ones in a bystander fashion remains to be defined despite the idea that T Reg -mediated suppression in vitro is non-Ag specific (18, 25). Some early studies suggest that Ag specificity may play a role in T Reg -mediated regulation in vivo (26, 27). Using a model of HA-specific T Reg , we have provided evidence that suppression of self-reactive T cells and prevention of autoimmune pneumonitis by T Reg in vivo is Ag specific. Similarly, HA-specific T Reg have been shown to specifically inhibit HA-specific allograft rejection (44, 45) or tumor rejection (46) . Whether this reflects the mode of action for naturally occurring T Reg in a nonlymphopenic setting remains to be confirmed, because T Reg development in these transgenic TCR mice might be different from that of naturally occurring T Reg cells in nontransgenic mice, which might influence the function of these transgenic T Reg cells. Thus, it will be important to develop a model that allows us to study how naturally occurring T Reg suppress autoimmunity in a nonlymphopenic host. Furthermore, the delineation of how T Reg are generated in the thymus will also help us to better understand their function.
How T Reg cells suppress activation of naive T cells with the same Ag specificity remains to be defined. We could envision three potential mechanisms for the observed Ag specificity in T Reg -mediated suppression in vivo: 1) T Reg could compete with self-reactive T cells for the available MHC/peptide ligands on DCs; 2) if cell-cell contact is also necessary for suppression in vivo, then the binding to DCs that present the same MHC/peptide ligand could serve as a mechanism to bring T Reg and self-reactive T cells together; and 3) T Reg could down-regulate the function of DCs that present the same MHC/peptide ligand to self-reactive T cells. Thus, future work should delineate these potential mechanisms responsible for T Reg -mediated suppression in vivo. In addition to the requirement for Ag specificity, we found that T Reg -mediated suppression in vivo was critically dependent on immunosuppressive cytokines, IL-10 and TGF-␤. These data suggest that the mechanisms by which T Reg -mediated suppression in vivo are far more complex and require multiple layers of regulation. How, then, do IL-10 and TGF-␤ contribute to Ag-specific immune regulation by T Reg in vivo? Our data indicate that both IL-10 and TGF-␤ may contribute to T Reg -mediated suppression in vivo by inhibiting the expansion and effector functions of self-reactive T cells. These suppressive cytokines could exert an effect on selfreactive T cells directly or through DCs indirectly. These observations are consistent with the findings of a previous study that IL-10 may play a role in the control effector T cell expansion by CD4 ϩ CD25 ϩ T Reg (47) . Furthermore, it has been shown that TGF-␤ signaling is required for in vivo expansion of CD4 ϩ CD25 ϩ T Reg (48, 49) , suggesting that TGF-␤ may also contribute to T Regmediated suppression in vivo by controlling the number of available Ag-specific T Reg . Consistent with previous observations on naturally occurring T Reg cells (22, 23, 35, 47), we have shown that clonotypic 6.5 ϩ CD25 ϩ T Reg cells produce high levels of TGF-␤ and IL-10. However, many other cell types may also produce soluble IL-10 and/or TGF-␤, including endogenous polyclonal T Reg in our system (50 -53) . Thus, it is not clear what type of cells produce IL-10 and/or TGF-␤, which are required for the observed immune suppression by Ag-specific T Reg cells. Thus, future studies will focus on identifying the cellular source of IL-10 and TGF-␤ as well as defining the precise roles of IL-10 and TGF-␤ in Ag-specific T Reg cell-mediated suppression in vivo.
In conclusion, we have demonstrated in a model of autoimmune pneumonitis that CD4 ϩ CD25 ϩ T Reg cells can suppress self-Agdriven activation of self-reactive T cells and protect mice from fatal pneumonitis in vivo. In this nonlymphopenic model, the suppression and protection by T Reg are Ag specific and dependent on both IL-10 and TGF-␤. These results indicate that T Reg can actively suppress autoimmunity in an Ag-specific manner and suggest an appealing therapeutic strategy using Ag-specific T Reg for treating autoimmune diseases, because they would not cause generalized immune suppression.
